BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 32431497)

  • 1.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
    Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
    Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
    Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
    Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
    Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
    Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
    Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
    Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
    Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
    Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: An in vitro and in vivo study.
    Yu S; Wang S; Xie Z; Yu S; Li L; Xiao H; Song Y
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111759. PubMed ID: 33892283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy.
    Wang H; Zhang Y; Zeng X; Pei W; Fan R; Wang Y; Wang X; Li J
    Int J Nanomedicine; 2021; 16():2373-2388. PubMed ID: 33790555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
    Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
    Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance.
    Zhang Y; Zeng X; Wang H; Fan R; Hu Y; Hu X; Li J
    Drug Deliv; 2021 Dec; 28(1):670-679. PubMed ID: 33792436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration.
    Duan Y; Zhang B; Chu L; Tong HH; Liu W; Zhai G
    Colloids Surf B Biointerfaces; 2016 May; 141():345-354. PubMed ID: 26874910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells".
    Hegazy H; Amin MM; Fayad W; Zakaria MY
    Int J Pharm; 2022 May; 619():121717. PubMed ID: 35378174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.